| 225 | |
| Search CDDW Abstracts | |
A NEW SYNDROME OF INTRAHEPATIC BILE DUCT PAUCITY IN A NOVA SCOTIAN KINDRED NOT LINKED TO JAG1 LOCUS
M
Cameron1,2, W Greer1, S Dyack2, A Otley2
Department
of Medicine, University of Calgary, Calgary, Alberta
BACKGROUND:
Alagille Syndrome, an autosomal dominant condition characterized by intrahepatic
bile duct paucity as well as other anomalies, is associated with mutations in
the JAG1 gene on chromosome 20p. We have identified a consanguineous kindred
with five individuals affected with an Alagille-like phenotype, but with apparent
autosomal recessive inheritance.
AIM: We hypothesized that the Alagille-like condition present
in this family was was a novel syndrome unrelated to a JAG1 mutation. We conducted
a linkage analysis study to determine whether this condition was linked to the
JAG1 gene.
METHODS: Facial photographs, medical histories and blood were
collected and DNA was extracted from thirty members of the affected kindred.
Four polymorphic DNA markers, D20S189, D20S894, D20S160, and D20S162, all closely
flanking the JAG1 gene, were used to genotype family members using a PCR-based
microsatellite analysis to follow the segregation of alleles through the family.
RESULTS: All five affected individuals had neonatal cholestasis
with intrahepatic bile duct paucity, with three having pulmonary stenosis. None
of the affected had posterior embryotoxin, or vertebral anomalies. Segregation
of alleles showed that two affected siblings had different haplotypes and did
not share any alleles at the JA1 locus. Further, in the second sibship, two
unaffected and one affected sibling inherited the same parental haplotypes.
CONCLUSIONS: Due to the inheritance pattern, the disease presentation
and the segregation pattern of the JAG1 gene in this family, we conclude that
the condition present in this family is not autosomal dominant Alagille syndrome
and is not caused by a JAG1 mutation. Future studies will include an analysis
of additional polymorphic markers linked to other genes associated with the
intracellular pathways involving JAG1.